TYMS and BCL2L1 were associated with the prognosis of colorectal cancer patients, which was consistent with previous reports of TYMS and BCL2L1 in other cancers (Fu et al., 2019; Obasi et al., 2018). Here, BCL2L1 is linked to cancer.